Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotherapy-Related Gene Signature in Prostate Cancer.
Fortis SP, Goulielmaki M, Aubert N, Batsaki P, Ouzounis S, Cavouras D, Marodon G, Stokidis S, Gritzapis AD, Baxevanis CN. Fortis SP, et al. Cancers (Basel). 2022 Oct 14;14(20):5032. doi: 10.3390/cancers14205032. Cancers (Basel). 2022. PMID: 36291815 Free PMC article.
HER2 as a prognostic factor in breast cancer.
Ménard S, Fortis S, Castiglioni F, Agresti R, Balsari A. Ménard S, et al. Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.
Watson DC, Moysi E, Valentin A, Bergamaschi C, Devasundaram S, Fortis SP, Bear J, Chertova E, Bess J Jr, Sowder R, Venzon DJ, Deleage C, Estes JD, Lifson JD, Petrovas C, Felber BK, Pavlakis GN. Watson DC, et al. Among authors: fortis sp. PLoS Pathog. 2018 Feb 23;14(2):e1006902. doi: 10.1371/journal.ppat.1006902. eCollection 2018 Feb. PLoS Pathog. 2018. PMID: 29474450 Free PMC article.
Correction: Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.
Watson DC, Moysi E, Valentin A, Bergamaschi C, Devasundaram S, Fortis SP, Bear J, Chertova E, Bess J Jr, Sowder R, Venzon DJ, Deleage C, Estes JD, Lifson JD, Petrovas C, Felber BK, Pavlakis GN. Watson DC, et al. Among authors: fortis sp. PLoS Pathog. 2018 Oct 11;14(10):e1007345. doi: 10.1371/journal.ppat.1007345. eCollection 2018 Oct. PLoS Pathog. 2018. PMID: 30308061 Free PMC article.
Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients.
Janssen N, Fortis SP, Speigl L, Haritos C, Sotiriadou NN, Sofopoulos M, Arnogiannaki N, Stavropoulos-Giokas C, Dinou A, Perez S, Pawelec G, Baxevanis CN, Shipp C. Janssen N, et al. Among authors: fortis sp. Breast Cancer Res Treat. 2017 Jan;161(1):51-62. doi: 10.1007/s10549-016-4037-z. Epub 2016 Oct 27. Breast Cancer Res Treat. 2017. PMID: 27787640
45 results